The following are our studies currently being enrolled. Please fill out the form below to enroll.
Heart Failure Study: - Diagnosis of heart failure (NYHA Class II-IV) - LVEF > 40% documented by echocardiography within 12 months
Hypertension with Chronic Kidney Disease: - Systolic Blood Pressure over 140 - Mild to moderate Chronic Kidney Disease (eGFR between 25 and 75) - Must be taking an ACE or an ARB
COPD (Chronic Obstructive Pulmonary Disease): - Eosinophil count greater than 300 - Use of ICS-based triple COPD standard of care - At least 2 moderate COPD exacerbations within 12 months
Cardiovascular and Type II Diabetes with Obesity: - Age 55 or above - Established Cardiovascular Disease (prior MI{myocardial infarction}/heart attack, prior stroke, symptomatic peripheral arterial disease {PAD}) - No heart attack, stroke, or hospitalization for unstable angina or transient ischemic attack within 60 days prior to screening - No treatment with any GLP-1 medications within 90 days before screening - No major depressive disorder, severe psychiatric disorder, or history of suicidal attempt - No history of pancreatitis
Hypertriglyceridemia/Very High Triglycerides: Research Study for patients that have triglycerides over 500 on more than one occasion and on a statin medication